cord blood-derived T-regulatory cells (CK0804) - Cellenkos
Jakafi oral (ruxolitinib) - Novartis, Incyte
https://www.businesswire.com/news/home/20201230005038/en/Incyte-and-Cellenkos-Enter-into-Global-Development-Collaboration-Agreement-for-CK0804
 
Dec 30, 2020
 
Prev Next